Methods for Identifying Cancer Risk
Provided herein are tissue-specific differential methylated regions (T-DMRs) and cancer-related differential methylated regions (C-DMRs) and methods of use thereof. In one embodiment of the invention, there are provided methods of detecting a cell proliferative disorder by detecting altered methylation in one or more DMRs identified herein. In another embodiment of the invention, there are provided methods of determining clinical outcome by detecting altered methylation in one or more DMRs identified herein.
Patents:WO 2,010,062,914
Inventor(s):
FEINBERG ANDREW P [US]
Type of Offer:
Licensing
« More Biotech Patents